Press Releases

KEFEA: We will not let patients go without medication

In response to reports claiming companies are not providing medication on credit as a result of the unfavourable for our country developments in the economy, the Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA) assures consumers that the...

Daan Gijbels is the new president of KEFEA

Mr Daan Gijbels, of Dutch descent and Area General Manager for GlaxoSmithKline (Cyprus), is the new president of the Cyprus Association of Research & Development Pharmaceutical Companies (KEFEA). He took over from Jacqueline Anastassiades, General Manager of Merck...

KEFEA met with Giorgos Lillikas

The Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA), met with Presidential Candidate Giorgos Lillikas, within the framework of its meetings with the presidential candidates. "We had a very substantive dialogue with Mr. Lillikas and we...

KEFEA’s position on the drugs pricing system

The Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA) expresses the belief that the change in the pricing policy for medicines, as has been approved by Cabinet, ensures, under the circumstances, the continued availability of the majority...

KEFEA is strong supporter of GESY

The Cyprus Association of Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA) commends the decision of the Cabinet to approve the implementation proposal of a National Health System (GESY) in Cyprus, which was presented by the Ministry of...

Innovative Medicines Initiative meeting in Cyprus

€2 bln for research programmes An informative meeting, which aims to promote Cypriot participation in the present and future calls of the European Innovative Medicines Initiative (IMI) project, the submission of research proposals and the creation of an IMI network in...

KEFEA sounds the alarm on pharmaceuticals

The Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA) has been following with great concern the sudden change in policy on behalf of the Ministry of Health, in relation to the application of contracts for the purchase of medications....